Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

RSS icon

Medrad taps Darby as VP of interventional unit

Medrad Interventional has named Jack Darby as its vice president (VP) and general manager of diagnostic and therapeutic lines of business.

Toshiba offers new features for Infinix-i cardiovascular system

Toshiba America Medical Systems has upgraded its line of Infinix-i cardiovascular x-ray systems to include volume navigation 3D roadmapping, new monitors and compatibility with Maquet Magnus tables.

OrbusNeich sues its principal investigator

OrbusNeich has filed a lawsuit against Pavel Cervinka, MD, and the Masaryk Hospital in Usti nad Labem, Czech Republic, alleging that Cervinka, principal investigator of a trial evaluating the companys Genous stent, committed "unlawful acts." The company has asked for an injunction against the presentation or publication of the study.

Stroke: MI incidence doubles after TIA

After a transient ischemic attack (TIA), the annual incidence of MI is almost 1 percent, double that of the general population and risk is higher in patients aged 60 and under, according to a report published in the March 28 issue of Stroke.

Q&A: Why was the TRIGGER-PCI pulled so soon?

After the TRIGGER-PCI trial, which was developed to evaluate the efficacy of prasugrel and clopidogrel, was pulled due to a low rate of cardiovascular events, clinicians are left wondering how this decision could impact clinical practice, and whether platelet reactivity testing will have a role in the future of clinical practice. Cardiovascular Business News spoke with platelet expert Steven R. Steinhubl, MD, of Geisinger Health System in Danville, Pa., who was not invovled in the trial, about how the halted TRIGGER-PCI trial, compounded by negative results of the GRAVITAS trial, could impact clinical practice.

Kings of CABG: Surgeons Adapt Methods for Patients

Coronary artery bypass graft (CABG) surgery has undergone many changes, and continues to evolve. Some of the debates currently being played out within clinical practice include radial artery vs. saphenous vein grafts, open vs. endoscopic vein harvesting, CABG on- vs. off-pump and how best to reduce CABG-related stroke.

Next-Generation Stent Technologies: Shedding the Metal

Second-generation drug-eluting stents (DES) are working better, but they are not perfect, especially in sicker patients. Therefore, a variety of models are being developed and tested, but most likely, it wont result in a one-size-fits-all solution.

PinnacleHealth Heart Recovery Program Aims to Stabilize Unstable Shock Patients

Offered in cooperation with Abiomed

The Impella hemodynamic support system is finding another niche: in patients who have suffered massive heart attacks complicated by cardiogenic shock.

Displaying 2249 - 2256 of 2712

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.